146 Participants Needed

Perceptual Training Techniques for Body Dysmorphic Disorder

JD
AS
DL
RA
Overseen ByResearch Analyst
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Centre for Addiction and Mental Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

Yes, participants must be medication-free for at least 8 weeks before joining the trial, except for certain short-term medications for insomnia or anxiety, which have specific usage limits.

What data supports the effectiveness of the treatment for Body Dysmorphic Disorder?

Research suggests that treatments focusing on visual attention and perception, like perceptual retraining, may help improve symptoms of Body Dysmorphic Disorder (BDD). Studies show that modifying visual attention can enhance brain connectivity and reduce symptom severity, indicating potential benefits for BDD treatment.12345

Is perceptual training for body dysmorphic disorder safe for humans?

The research does not report any safety concerns for perceptual training techniques in humans, suggesting it is generally safe.13456

How does perceptual training differ from other treatments for body dysmorphic disorder?

Perceptual training for body dysmorphic disorder is unique because it focuses on modifying visual attention and processing biases, which are core issues in the disorder. Unlike traditional treatments like cognitive behavioral therapy or medication, this approach aims to retrain how individuals visually perceive themselves, potentially improving holistic visual processing and reducing attention to perceived flaws.14578

What is the purpose of this trial?

A core symptom of body dysmorphic disorder (BDD) is perceptual distortions for appearance, which contributes to poor insight and delusionality, limits engagement in treatment, and puts individuals at risk for relapse. Results from this study will provide a comprehensive mechanistic model of brain, behavioral, and emotional contributors to abnormal perceptual processing, as well as how malleable it is with visual modulation techniques. This will lay the groundwork for next-step translational perceptual retraining approaches.

Research Team

JD

Jamie D Feusner, M.D.

Principal Investigator

Centre for Addiction and Mental Health

Eligibility Criteria

This trial is for individuals aged 18-40 with Body Dysmorphic Disorder (BDD) or subclinical BDD, focused on facial concerns. Participants must meet specific criteria on the Dysmorphic Concern Questionnaire and be medication-free for at least 8 weeks. Healthy controls with low scores on the same questionnaire can also join. Exclusions include other major mental disorders, current psychotherapy, neurological issues, pregnancy, certain medical conditions affecting brain function, and visual acuity worse than 20/35.

Inclusion Criteria

I am 18-40, have intense concern about my face or head's appearance, and haven't taken medication for it in 8+ weeks.
I am 18-40, worried about my face or head appearance, and haven't taken any related medication for 8 weeks.

Exclusion Criteria

Healthy Controls: Participants with any current Axis I disorder, lifetime bipolar disorder or psychotic disorder, or psychiatric medication
I have body dysmorphic disorder but no bipolar, psychotic disorders, or current CBT.
All participants: Participants with neurological disorders, pregnancy, current major medical disorders affecting cerebral metabolism, current risk of suicide with a plan and intent, ferromagnetic metal implantations or devices, and visual acuity worse than 20/35 for each eye
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants undergo baseline assessments including fMRI, eye-tracking, and emotional valence measurements

1 week
1 visit (in-person)

Treatment

Participants receive visual modulation techniques to assess changes in perceptual functioning and brain activity

1 week
Multiple sessions (in-person)

Follow-up

Participants are monitored for changes in perceptual functioning and brain activity post-treatment

1-2 weeks
1 visit (in-person)

Treatment Details

Interventions

  • attentional modulation
  • naturalistic viewing
  • perceptual modulation
Trial Overview The study examines how people with BDD process visual information about appearance and tests if attentional and perceptual modulation techniques can alter this processing. It aims to understand the brain's role in these distortions and develop new treatment approaches based on retraining perception.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: perceptual modulationExperimental Treatment1 Intervention
Group II: naturalistic viewingExperimental Treatment1 Intervention
Group III: attention modulationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Centre for Addiction and Mental Health

Lead Sponsor

Trials
388
Recruited
84,200+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

University of Toronto

Collaborator

Trials
739
Recruited
1,125,000+

University of Alabama at Birmingham

Collaborator

Trials
1,677
Recruited
2,458,000+

Findings from Research

Individuals with body dysmorphic disorder (BDD) experience unique visual processing abnormalities that set it apart from other mental health disorders, indicating a need for tailored treatment approaches.
Current treatments like cognitive behavioral therapy (CBT) could be enhanced by incorporating perceptual mirror retraining and visual training programs to address these specific visual abnormalities, potentially improving treatment outcomes.
Treatment Modifications and Suggestions to Address Visual Abnormalities in Body Dysmorphic Disorder.Beilharz, F., Rossell, SL.[2020]
Imagery rescripting (ImR) was tested as a brief intervention for body dysmorphic disorder (BDD) in a study involving six individuals, focusing on their aversive memories related to appearance.
Four out of six participants showed significant improvement in their BDD symptoms within the first week after the ImR intervention, suggesting that this technique may be a promising addition to cognitive-behavioral therapy for BDD.
Imagery Rescripting for Body Dysmorphic Disorder: A Multiple-Baseline Single-Case Experimental Design.Willson, R., Veale, D., Freeston, M.[2019]
In a study involving 40 individuals with body dysmorphic disorder (BDD), interpretation bias modification (IBM) training significantly improved benign interpretation biases and reduced threat biases compared to a placebo control, leading to greater reductions in BDD symptoms.
The benefits of IBM were particularly pronounced in individuals with higher pre-treatment BDD symptoms, and these effects were largely maintained one month after treatment, suggesting that IBM may be an effective intervention for managing BDD.
Modifying interpretation biases in body dysmorphic disorder: Evaluation of a brief computerized treatment.Summers, BJ., Cougle, JR.[2018]

References

Treatment Modifications and Suggestions to Address Visual Abnormalities in Body Dysmorphic Disorder. [2020]
Imagery Rescripting for Body Dysmorphic Disorder: A Multiple-Baseline Single-Case Experimental Design. [2019]
Modifying interpretation biases in body dysmorphic disorder: Evaluation of a brief computerized treatment. [2018]
Neural and behavioral effects of modification of visual attention in body dysmorphic disorder. [2022]
Selective attention to imagined facial ugliness is specific to body dysmorphic disorder. [2022]
A virtual reality study of cognitive biases in body dysmorphic disorder. [2021]
Parameters of visual processing abnormalities in adults with body image concerns. [2019]
Altering Visual Perception Abnormalities: A Marker for Body Image Concern. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security